Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by CurlyMickon Jul 15, 2014 6:27pm

80 Views

Post# 22748531

RE:RE:RE:RE:RE:RE:RE:WAITING FOR SOMETHING

There have been less KNE shares traded in the past ten days than most of us long time holders who contribute here own individually.

If the announcement includes another photo opp of Gordo leering longingly and lustfulfully at a bowl of StrixNB laced water, I'll forever be a basher.

I want to hear about Dispersin B's future...not dog breath and cat scratch fever.

Just saying.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?